Navigation Links
Consumer group seeks Sibutramine ban

A consumer group has petitioned the Food and Drug Administration to ban the prescription diet drug sibutramine. Public Citizen says the drug, sold as Meridia, is associated with 29 deaths, including 19 from// cardiovascular causes such as heart attacks. But obesity experts say it's difficult to determine if people died because of Meridia or because they were obese, which put them at increased risk for many diseases and premature death.

This is not the first time a diet drug has come under fire. In 1998, the FDA pulled two diet drugs from the market, fenfluramine and dexfenfluramine, because of concern over heart-valve problems. Sibutramine, marketed as Meridia by Abbott Laboratories, works on two brain chemicals that control appetite and make patients feel full. It was approved in 1997 for people who are obese.

Average weight loss from using the medication is 5% to 9% in four to six months. At the time of its approval, experts warned that the drug was not meant for people with heart disease. Studies showed that the drug slightly increased the blood pressure of some patients and substantially increased it in others.
'"/>




Page: 1

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Identifying What Consumers Look For On Food Stuff Labels
3. Consumers Becoming More Health Conscious Than Calorie Conscious
4. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
5. Consumers of soft drinks to be more alert
6. Consumers Worried About Trans-Fats The Most
7. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
8. Health care system “Consumer friendly” by 207
9. Chicken Prices Show an Upward Trend – Consumers, Not Scared Chicken Anymor
10. Consumer Court Dismisses Rs 143 Crore Negligence Claim
11. Apex Consumer Court Rejects Rs 143 Cr Medical Negligence Claim
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Consumer group seeks Sibutramine ban

(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
(Date:8/31/2015)... ... ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ... More than 30 million Americans are missing all their teeth in one or both ... National Association of Dental Laboratories (NADL) created the “What’s In Your Mouth?” campaign to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad ... a ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of ... via AdvantaClean’s National Call Center and website since Aug. 17. , The Greens ...
(Date:8/31/2015)... ... ... Finnleo , a leader in the sauna industry, is pleased to announce ... re-styled and re-designed “Hallmark Series” updates the Passport series with a feature rich, portable ... and a more upscale feel than the current Passport a beautiful 6-bar two-toned curved ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4
... Mayo Clinic researchers have discovered two mutations responsible for ... ago. The researchers say their study -- appearing in ... neural pathway that may help understand a variety of ... now because of Next Generation genomic sequencing technology," says ...
... , SATURDAY, April 30 (HealthDay News) -- After reviewing ... up to age 3, researchers found that about 4 percent ... higher among the youngest babies, the study found. "Almost ... 2 months, received more than twice the dose that they ...
... SUNDAY, May 1 (HealthDay News) -- Increased bursts of sleep in ... new study included 23 parents who kept daily sleep records for ... at the start of the study. The researchers analyzed the total ... The infants had uneven bursts of sleep, with the amount ...
... at extremely low levels, is associated with increased blood pressure ... 1, at the Pediatric Academic Societies (PAS) annual meeting in ... increased risk of having high blood pressure, or hypertension, as ... and kidney disease and is the third leading contributor to ...
... parent or caregiver to look in the rearview mirror while ... of their safety restraints. A study on child self-unbuckling by ... first unbuckle were age three and under and that many ... a 3.5-fold increased risk for serious injuries. , "We found ...
... study in the May 1 issue of the journal Sleep ... among infants are significantly associated with growth spurts in body length. ... 24-hour sleep duration increasing at irregular intervals by an average of ... sleep episodes per day also increased in intermittent bursts of an ...
Cached Medicine News:Health News:Mayo Clinic finds new genetic cause of neurodegeneration 2Health News:Young Kids' Prescriptions Not Always on the Mark 2Health News:Extra Sleep in Infants Seems to Signal Growth Spurts 2Health News:Living with a smoker may raise blood pressure in boys 2Health News:Little fingers, big trouble: Yale study sheds light on child self-unbuckling 2Health News:Study is the first to link sleep duration to infant growth spurts 2
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, ... on the emerging field of regenerative medicine, today ... at Chicago -based Rush University ... evaluating activity of escalating doses of AST-OPC1 (oligodendrocyte ... and motor complete cervical spinal cord injury (SCI). ...
(Date:8/31/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company ... for the treatment of diseases of the central nervous ... IND submission has passed review by the US Food ... Phase 1 clinical trial in patients with metastatic colon ... to 31 December 2015. Bionomics, CEO & ...
(Date:8/30/2015)... LONDRES, August 30, 2015 ... de l cuidado al paciente ... trayecto   Royal Philips  (NYSE: ... de IntelliSpace Cardiovascular , un sistema web de ... para acceder, analizar y compartir imágenes cardiovasculares e información ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: